Michel Hamon wins 2017 ECNP Neuropsychopharmacology award

ECNP’s premier research prize, the ECNP Neuropsychopharmacology Award, has this year been awarded to Michel Hamon, France, for his ground-breaking work on serotonin and the role of the brain receptors for serotonin in the treatment of psychiatric illness. The award will be conferred at the 30th ECNP Congress on 2-5 September 2017 in Paris, France, where Michel Hamon will deliver the ECNP Neuropsychopharmacology Award plenary lecture. The ECNP Neuropsychopharmacology Award is given every year, alternating between basic science and clinical research, and comes with a prize of € 10,000.

Read the press release...

New horizons in developmental neuropsychopharmacology

Message from the President - Celso Arango's thoughts on developmental neuropsychopharmacology.


Scientists show cognitive enhancing drugs can improve chess play

The first study to both show and measure the effects of cognitive-enhancing drugs such as modafinil, methylphenidate (best known under the trade name Ritalin), and caffeine, on chess playing is being published in the peer-reviewed ECNP journal European Neuropsychopharmacology.

Read more

Register now!

You can benefit from lower fees if you register on or before 15 August.

Register here

Become A member

Become a member today and pay a lower registration fee for the next ECNP Congress taking place on 2-5 September in Paris.

View membership fees

Why the ECNP Congress?

" annual congress attended by 4,000-6,000 people who come with extremely heterogeneous backgrounds...and we're here together for 3-4 days sharing our experiences, sharing the results of our studies, networking and mingling..."

ECNP President Celso Arango tells us how he became a child psychiatrist and shares his vision on ECNP and the annual ECNP Congress.

About ECNP

The European College of Neuropsychopharmacology (ECNP) is a pan-European scientific association founded in 1987 to encourage innovative research across the neurosciences and to translate new knowledge on fundamental disease mechanisms into new medicines and clinical applications.

As Europe’s leading interdisciplinary forum for the science and treatment of disorders of the brain, ECNP promotes the communication and cross- fertilisation of high-quality experimental and clinical research across the field of neuroscience.

ECNP is a non-profit member-based association, independently governed and self-funded. ECNP is a public-interest-serving entity